EI
MRKR icon

Ellevest Inc’s Marker Therapeutics MRKR Stock Holding History

Ellevest Inc’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed – – 1256
2020
Q1 		$0 Buy
+3
New +$76 ﹤0.01% 1223

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ellevest Inc's MRKR Position: Q2 2020 in Review

Ellevest Inc sold out of Marker Therapeutics (MRKR) in Q2 2020, closing a stake of 3 shares.

Ellevest Inc first reported a position in MRKR in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 63 funds tracked by Wall St. Rank hold MRKR as of Q2 2020.

  • Ellevest Inc reported no remaining Marker Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Ellevest Inc sold 3 Marker Therapeutics shares in Q2 2020.
  • Ellevest Inc first reported a position in Marker Therapeutics in Q1 2020 and held it in 1 quarter.
  • Ellevest Inc's Marker Therapeutics position peaked at $0 in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.